中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

维生素A缺乏与HCV慢性感染和干扰素的抗病毒治疗无应答相关

作者: 迟秀梅 发布日期: 2012-12-26 阅读次数:
  • 分享到:

用微信扫码二维码

分享至好友和朋友圈

维生素A缺乏与HCV慢性感染和干扰素的抗病毒治疗无应答相关

    最近的数据表明,维生素A能调节I型干扰素受体的表达,增强α-干扰素抑制丙型肝炎病毒(HCV)复制效果。本研究旨在探讨慢性丙型肝炎病毒感染的患者维生素A缺乏的流行病学,评估是否维生素A缺乏症与干扰素的抗病毒治疗的无应答相关。该分析包括了199名连续治疗的初治慢性丙型肝炎患者,检测治疗前血清维生素A25-OH维生素D;  119名健康献血者作为对照组。HCV阳性患者的血清维生素A的中位数(四分位数间距)显着低于对照组:256纳克/毫升(128-440)和742624-942P <0.0001)。199名患者中有122人获得了持续病毒学应答,109名病毒分型为难治型人群中有46人获得持续病毒学应答。后者中39/10437.5%)患者无应答。在多变量分析中,抗病毒治疗无应答的预测指标有:IL-28B基因型为T /*基因型,基线血清γGT> 60 IU/ mLHCV RNA>600000 IU/ mL,维生素A≤100 ng / mL以及累积服用利巴韦林剂量≤80%。17例患者(9.0%),同时有血清维生素A≤100 纳克/毫升和维生素D≤20 纳克/毫升;同时具有维生素AD缺乏被认为是抗病毒治疗无应答的一个强有力的独立预测因素。结论:目前慢性丙型肝炎病毒感染血清维生素A缺乏症的患者比例较高。这与抗病毒治疗无应答具有相关性。

吉林大学第一医院肝胆胰内科 迟秀梅 摘译

本文首次发表于[Hepatology. 2012 Dec 5]

Vitamin A deficiency is associated with HCV chronic infection and with unresponsiveness to interferon based antiviral therapy

Recent data suggest that vitamin A modulate the expression of type I interferon receptor enhancing the anti replication effect of interferon-α on hepatitis C virus (HCV). This study aimed to investigate the prevalence of vitamin A deficiency among patients with chronic  HCV infection and to assess whether vitamin A deficiency could be associated with unresponsiveness to interferon based antiviral therapy. The analysis included 199 consecutive treatment-naïve chronic hepatitis C patients in whom pre-treatment serum vitamin A and 25-OH vitamin D were measured; 119 healthy blood donors were used as controls. Median (inter-quartile range) serum vitamin A in HCV positive patients was significantly lower than in controls: 256 ng/mL (128-440) Vs 742 (624-942, p<0.0001). Overall sustained viral response was achieved in 122/199 patients, 46/109 infected by difficult to treat HCV genotypes. In these latter, 39/104 (37.5%) were non responders. At multivariate analysis, non response to antiviral therapy was predicted by carriage of IL-28B T/* genotypes, baseline serum levels of γGT >60 IU/mL, of HCV RNA >600.000 IU/mL, of vitamin A ≤100 ng/mL and the cumulative dose of ribavirin ≤80%. Seventeen patients (9.0%) had both serum levels of vitamin A ≤100 ng/mL and of vitamin D ≤20 ng/mL; the presence of the combined vitamin A and D deficiency was found to be a strong independent predictor of non response to antiviral therapy. Conclusions: a high percentage of patients with chronic HCV infection present serum vitamin A deficiency. This condition is associated with non response to antiviral therapy.  点击下载此文件

  • 分享到:

用微信扫码二维码

分享至好友和朋友圈

作者: 迟秀梅 发布日期: 2012-12-26 阅读次数: